TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) – William Blair boosted their Q2 2024 EPS estimates for shares of TransMedics Group in a research report issued on Tuesday, April 30th. William Blair analyst R. Daniels now forecasts that the company will post earnings per share of $0.10 for the quarter, up from their previous estimate […] Read this story